The report covers forecast and analysis for the enzyme-linked immunosorbent assay (ELISA) testing market on a global and regional level. The study provides historic data of 2016 along with a forecast for 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the enzyme-linked immunosorbent assay (ELISA) testing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the enzyme-linked immunosorbent assay (ELISA) testing market on a global level.
In order to give the users of this report a comprehensive view on the enzyme-linked immunosorbent assay (ELISA) testing market, we have to include competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein test type segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research& development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.
The study provides a decisive view on the enzyme-linked immunosorbent assay (ELISA) testing market by segmenting the market based on test type, application, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2022. Based on test type the market is segmented into sandwich ELISA, indirect ELISA, multiple and portable ELISA and competitive ELISA. Key applications covered under this study include Immunology, inflammation, infectious diseases, cancer, protein quantification and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for enzyme-linked immunosorbent assay (ELISA) testing based on individual test type and applications in all the regions and countries.
The report also includes detailed profiles of end players such as Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R & D Systems Inc. and ZEUS Scientific, Inc. among others.
This report segments the global enzyme-linked immunosorbent assay (ELISA) testing market as follows:
Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Test Type Segment Analysis
- Sandwich ELISA
- Indirect ELISA
- Multiple and portable ELISA
- Competitive ELISA
Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Application Segment Analysis
- Immunology
- Inflammation
- Infectious diseases
- Cancer
- Protein quantification
- Others
Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Regional Segment Analysis
- North America
- U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
